Elevance Health Inc (ELV) reports robust financial performance with a focus on strategic growth and shareholder returns, ...

Elevance Health (NYSE: ELV) Q4 2024 Earnings Call Jan 23, 2025, 8:30 a.m. ET ...

Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, expectations were $3.8. Operator: Ladies and gentlemen, thank you for ...

After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

The healthcare industry is undergoing rapid transformation, driven by advancements in technology, artificial intelligence, ...

According to LCH Investments, over 200 hedge funds are Tiger Cubs, funds started by former employees of Tiger Management, the ...

Elevance Health Inc (ELV) stock saw a decline, ending the day at $405.4 which represents a decrease of $-5.84 or -1.42% from the prior close of $411.24. The stock opened at $410.18 and touched a low ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Barclays raised the firm’s price target on Elevance Health (ELV) to $512 from $501 and keeps an Overweight rating on the shares post the Q4 ...